Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease

被引:0
|
作者
Xiao-Wei Li
Shao-Shan Liang
Wei-Bo Le
Shui-Qin Cheng
Cai-Hong Zeng
Jin-Quan Wang
Zhi-Hong Liu
机构
[1] Fuyang People’s Hospital,Department of Nephroloy
[2] Nanjing University of Medicine,National Clinical Research Center of Kidney Diseases, Jinling Hospitial
来源
Journal of Nephrology | 2016年 / 29卷
关键词
Minimal change lesions; IgA nephropathy; Long-term outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:567 / 573
页数:6
相关论文
共 50 条
  • [21] Clinical Characteristics of Concomitant Nephrotic IgA Nephropathy and Minimal Change Disease in Children
    Shen, Huijun
    Gu, Weizhong
    Mao, Jianhua
    Zhu, Xiujuan
    Jin, Xia
    Fu, Haidong
    Liu, Aimin
    Shu, Qiang
    Du, Lizhong
    NEPHRON, 2015, 130 (01) : 21 - 28
  • [22] Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease
    Woo, Keng Thye
    Wong, Kok Seng
    Choong, Hui Lin
    Foo, Marjorie
    Chin, York Moi
    Chan, Choong Meng
    CLINICAL NEPHROLOGY, 2013, 80 (01) : 79 - 79
  • [23] Adult-onset Minimal Change Disease with IgA Nephropathy and Hepatitis C
    Chowdhury, Waliul
    Saleem, Tahira Sabeen
    Lodhi, Muhammad Uzair
    Syed, Intekhab Askari
    Iqbal, Hafiz Imran
    Rahim, Mustafa
    CUREUS, 2018, 10 (02):
  • [24] The diagnosis of minimal change disease in diabetic nephropathy
    Stokes, M. Barry
    THESCIENTIFICWORLDJOURNAL, 2005, 5 : 828 - 833
  • [25] Long-Term Outcomes of Patients Treated With Tacrolimus as First Line Therapy for Minimal Change Disease
    Seneschall, Charlotte
    Dattani, Rakesh
    Cairns, Tom
    McAdoo, Stephen P.
    Medjeral-Thomas, Nicholas R.
    Griffith, Megan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 503 - 503
  • [26] Rituximab for minimal change disease in adults: long-term follow-up
    Bruchfeld, Annette
    Benedek, Samiha
    Hilderman, Marie
    Medin, Charlotte
    Snaedal-Jonsdottir, Sunna
    Korkeila, Maarit
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 851 - 856
  • [27] Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
    Leong, Leanne Ca-Yin
    Hong, Wei-Zhen
    Khatri, Priyanka
    CLINICAL KIDNEY JOURNAL, 2022, 15 (03) : 569 - 570
  • [28] Key pathological features characterize minimal change disease-like IgA nephropathy
    Wang, Tsung-Yueh
    Chang, Fu-Pang
    Yang, An-Hang
    Ka, Shuk-Man
    Chen, Ann
    Hsieh, Jyh-Tong
    Chen, Fan-Yu
    Lee, Tsung-Lun
    Tseng, Po-Yu
    Tsai, Ming-Tsun
    Li, Szu-Yuan
    Yang, Chih-Yu
    Chen, Jinn-Yang
    Lin, Chih-Ching
    Tarng, Der-Cherng
    PLOS ONE, 2023, 18 (07):
  • [29] Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
    Gutierrez, Eduardo
    Zamora, Isabel
    Antonio Ballarin, Jose
    Arce, Yolanda
    Jimenez, Sara
    Quereda, Carlos
    Olea, Teresa
    Martinez-Ara, Jorge
    Segarra, Alfons
    Bernis, Carmen
    Garcia, Asuncion
    Goicoechea, Marian
    Garcia de Vinuesa, Soledad
    Rojas-Rivera, Jorge
    Praga, Manuel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1753 - 1760
  • [30] OUTCOME OF CHILDHOOD MINIMAL-CHANGE DISEASE
    COOVADIA, HM
    ADHIKARI, M
    LANCET, 1989, 1 (8648): : 1199 - 1200